• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2006-2009 年丹麦肠球菌菌血症的发病率、临床特征和 30 天死亡率:一项基于人群的队列研究。

Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study.

机构信息

Department of Clinical Microbiology, Copenhagen University Hospital, Herlev Hospital, Herlev, Denmark; Department of Clinical Microbiology, Copenhagen University Hospital, Hvidovre Hospital, Hvidovre, Denmark.

出版信息

Clin Microbiol Infect. 2014 Feb;20(2):145-51. doi: 10.1111/1469-0691.12236. Epub 2013 May 6.

DOI:10.1111/1469-0691.12236
PMID:23647880
Abstract

Enterococci currently account for approximately 10% of all bacteraemias, reflecting remarkable changes in their epidemiology. However, population-based data of enterococcal bacteraemia are scarce. A population-based cohort study comprised all patients with a first episode of Enterococcus faecalis or Enterococcus faecium bacteraemia in two Danish regions during 2006-2009. We used data collected prospectively during clinical microbiological counselling and hospital registry data. We determined the incidence of mono- and polymicrobial bacteraemia and assessed clinical and microbiological characteristics as predictors of 30-day mortality in monomicrobial bacteraemia by logistic regression analysis. We identified 1145 bacteraemic patients, 700 (61%) of whom had monomicrobial bacteraemia. The incidence was 19.6/100 000 person-years (13.0/100 000 person-years for E. faecalis and 6.6/100 000 person-years for E. faecium). The majority of bacteraemias were hospital-acquired (E. faecalis, 45.7%; E. faecium, 85.2%). Urinary tract and intra-abdominal infections were the predominant foci for the two species, respectively. Infective endocarditis (IE) accounted for 25% of patients with community-acquired E. faecalis bacteraemia. Thirty-day mortality was 21.4% in patients with E. faecalis and 34.6% in patients with E. faecium. Predictors of 30-day mortality included age, co-morbidity and hospital-acquired bacteraemia. In addition, intra-abdominal infection, unknown focus and high-level gentamicin resistance were predictors of mortality in E. faecalis patients. E. faecium was associated with increased risk of mortality compared with E. faecalis. The study emphasizes the importance of enterococci both in terms of incidence and prognosis. The frequency of IE in patients with E. faecalis bacteraemia emphasizes the importance of echocardiography, especially in community-acquired cases.

摘要

肠球菌目前约占所有菌血症的 10%,反映了其流行病学的显著变化。然而,肠球菌菌血症的基于人群的数据却很少。本项基于人群的队列研究纳入了 2006-2009 年丹麦两个地区首次发生粪肠球菌或屎肠球菌菌血症的所有患者。我们使用临床微生物学咨询期间前瞻性收集的数据和医院登记数据。我们确定了单一致病菌血症和混合菌血症的发生率,并通过逻辑回归分析评估了临床和微生物学特征作为单一致病菌血症 30 天死亡率的预测因素。我们共确定了 1145 例菌血症患者,其中 700 例(61%)为单一致病菌血症。发病率为 19.6/100000 人年(粪肠球菌为 13.0/100000 人年,屎肠球菌为 6.6/100000 人年)。大多数菌血症为医院获得性(粪肠球菌 45.7%,屎肠球菌 85.2%)。尿路感染和腹腔内感染分别是两种菌的主要感染灶。感染性心内膜炎(IE)占社区获得性粪肠球菌菌血症患者的 25%。粪肠球菌和屎肠球菌患者的 30 天死亡率分别为 21.4%和 34.6%。30 天死亡率的预测因素包括年龄、合并症和医院获得性菌血症。此外,腹腔内感染、未知感染灶和高水平庆大霉素耐药是粪肠球菌患者死亡的预测因素。与粪肠球菌相比,屎肠球菌与死亡率增加相关。该研究强调了肠球菌在发病率和预后方面的重要性。粪肠球菌菌血症患者 IE 的发生率强调了超声心动图的重要性,尤其是在社区获得性病例中。

相似文献

1
Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study.2006-2009 年丹麦肠球菌菌血症的发病率、临床特征和 30 天死亡率:一项基于人群的队列研究。
Clin Microbiol Infect. 2014 Feb;20(2):145-51. doi: 10.1111/1469-0691.12236. Epub 2013 May 6.
2
Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.万古霉素敏感屎肠球菌和粪肠球菌菌血症患者的临床特征和结局——一项五年回顾性研究。
Eur J Clin Microbiol Infect Dis. 2010 Jan;29(1):107-14. doi: 10.1007/s10096-009-0830-5. Epub 2009 Nov 15.
3
Microbiological and clinical characteristics of vancomycin-resistant Enterococcus faecium bacteraemia in Taiwan: implication of sequence type for prognosis.台湾万古霉素耐药粪肠球菌菌血症的微生物学和临床特征:序列型对预后的影响。
J Antimicrob Chemother. 2012 Sep;67(9):2243-9. doi: 10.1093/jac/dks181. Epub 2012 May 22.
4
Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study.临床特征、易患因素和屎肠球菌与粪肠球菌血流感染的转归:一项前瞻性多中心队列研究。
Eur J Clin Microbiol Infect Dis. 2024 Oct;43(10):2011-2022. doi: 10.1007/s10096-024-04917-5. Epub 2024 Aug 8.
5
Single center experience of a vancomycin resistant enterococcal endocarditis cohort.单中心万古霉素耐药肠球菌性心内膜炎队列的经验。
J Infect. 2011 Dec;63(6):420-8. doi: 10.1016/j.jinf.2011.08.014. Epub 2011 Sep 6.
6
Australian Enterococcal Sepsis Outcome Programme annual report, 2013.《2013年澳大利亚肠球菌败血症结局项目年度报告》
Commun Dis Intell Q Rep. 2014 Dec 31;38(4):E320-6.
7
Enterococcal bacteraemia: predictive and prognostic risk factors for ampicillin resistance.肠球菌菌血症:氨苄西林耐药的预测和预后危险因素。
Epidemiol Infect. 2018 Dec;146(16):2028-2035. doi: 10.1017/S0950268818002479. Epub 2018 Aug 31.
8
Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.坦桑尼亚儿童血流感染中氨苄西林耐药和高水平庆大霉素耐药肠球菌的遗传相关性及危险因素分析
BMC Infect Dis. 2015 Feb 28;15:107. doi: 10.1186/s12879-015-0845-8.
9
[Study of a cohort of patients with Enterococcus spp. Bacteraemia. Risk factors associated to high-level resistance to aminoglycosides].[粪肠球菌菌血症患者队列研究。与氨基糖苷类高水平耐药相关的危险因素]
Rev Esp Quimioter. 2013 Sep;26(3):203-13.
10
Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.肠球菌菌血症:影响死亡率、住院时间和住院费用的因素。
Clin Microbiol Infect. 2013 Apr;19(4):E181-9. doi: 10.1111/1469-0691.12132. Epub 2013 Feb 7.

引用本文的文献

1
Clinical impact and risk factors of enterococcal bacteremia in children: a focus on vancomycin resistance and mortality.儿童肠球菌菌血症的临床影响及危险因素:以万古霉素耐药性和死亡率为重点
Eur J Clin Microbiol Infect Dis. 2025 Sep 18. doi: 10.1007/s10096-025-05263-w.
2
A 5-Year Epidemiological Study of Monomicrobial Enterococcal Bloodstream Infection in a Population-Based Cohort.一项基于人群队列的单微生物肠球菌血流感染的5年流行病学研究。
Open Forum Infect Dis. 2025 Aug 20;12(9):ofaf506. doi: 10.1093/ofid/ofaf506. eCollection 2025 Sep.
3
Optimizing Vancomycin Area under the Concentration-Time Curve Targets in Enterococcal Bacteremia: Balancing Efficacy and Nephrotoxicity.
优化肠球菌血症中万古霉素浓度-时间曲线下面积目标:平衡疗效与肾毒性
Yonsei Med J. 2025 Sep;66(9):609-617. doi: 10.3349/ymj.2024.0513.
4
Pharmacokinetic/pharmacodynamic parameters of teicoplanin for predicting clinical outcome of glycopeptide-susceptible bacteraemia.替考拉宁的药代动力学/药效学参数对预测糖肽类敏感菌血症临床结局的作用
JAC Antimicrob Resist. 2025 Aug 21;7(4):dlaf151. doi: 10.1093/jacamr/dlaf151. eCollection 2025 Aug.
5
Evaluation of Different Versions of the Duke Criteria for the Diagnosis of Infective Endocarditis Among Patients With Enterococcal Bacteremia; a Multicenter Study.肠球菌血症患者中不同版本杜克标准对感染性心内膜炎诊断的评估;一项多中心研究。
Open Forum Infect Dis. 2025 Jul 4;12(7):ofaf408. doi: 10.1093/ofid/ofaf408. eCollection 2025 Jul.
6
Impact of vancomycin resistance on attributable mortality among Enterococcus faecium bloodstream infections: propensity score analysis of a large, multicentre retrospective study.粪肠球菌血流感染中万古霉素耐药性对归因死亡率的影响:一项大型多中心回顾性研究的倾向评分分析
J Antimicrob Chemother. 2025 Sep 3;80(9):2466-2473. doi: 10.1093/jac/dkaf242.
7
The MEFIER Score-A Risk Score to Stratify Infective Endocarditis in Patients With Bacteremia Based on an 11-Year Territory-Wide Cohort.MEFIER评分——一种基于11年全地区队列研究对菌血症患者感染性心内膜炎进行分层的风险评分。
Open Forum Infect Dis. 2025 May 12;12(6):ofaf287. doi: 10.1093/ofid/ofaf287. eCollection 2025 Jun.
8
Genomic epidemiology of vancomycin-resistant Enterococcus faecium in Eastern Denmark from 2020 to 2022, and identification of vanB Tn1549 insertion sites.2020年至2022年丹麦东部耐万古霉素屎肠球菌的基因组流行病学及vanB Tn1549插入位点的鉴定
Eur J Clin Microbiol Infect Dis. 2025 Jun;44(6):1425-1432. doi: 10.1007/s10096-025-05091-y. Epub 2025 Apr 1.
9
High-Risk VREfm Clones and Resistance Determinants in a Thai Hospital.泰国一家医院中的高风险屎肠球菌耐万古霉素克隆株及耐药决定因素
Antibiotics (Basel). 2025 Feb 24;14(3):229. doi: 10.3390/antibiotics14030229.
10
Whole-Genome Sequencing of Linezolid-Resistant and Linezolid-Intermediate-Susceptibility Clinical Isolates in a Mexican Tertiary Care University Hospital.墨西哥一家三级护理大学医院中耐利奈唑胺和中介敏感临床分离株的全基因组测序
Microorganisms. 2025 Mar 19;13(3):684. doi: 10.3390/microorganisms13030684.